Review Article
The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity
Table 1
Summarizing the anti-inflammatory effects of irisin in various inflammation models.
| |||||||||||||||||||||||||||||||||||||||||||||||||||
LPS, lipopolysaccharide; TNF-α, tumor necrosis factor α; IL-6, interleukin 6; MCP-1, monocyte chemotactic protein 1; NF-κB, nuclear factor-κB; IL-1β, interleukin 1β; KC, keratinocyte chemoattractant; HMGB1, high mobility group box 1; COX2, cyclooxygenase-2; CCL2, chemokine (C-C motif) ligand 2; CXCL1, chemokine (C-X-C motif) ligand 1; ICAM-1, intercellular cell adhesion molecule-1; VCAM-1, vascular cell adhesion protein 1; ALI, acute lung injury; MAPK, mitogen-activated protein kinase; IBDs, inflammatory bowel diseases; TNBS, 2,4,6-trinitrobenzenesulfonic acid; DSS, dextran sodium sulfate; PA, palmitic acid; PRMT3, protein arginine methyltransferase-3. |